PropThink: Titan Files NDA on Probuphine; Partner Waits

Published October 29, 2012

PropThink: Titan Files NDA on Probuphine; Partner Waits
Filed under: Drug Abuse and Addiction
By Jason Napodano, CFA Monday morning, Titan Pharmaceuticals (OTC:TTNP) announced it had filed a New Drug Application (NDA) to the U.S. FDA on Probuphine for the maintenance treatment of opioid dependence …
Source